National Health Investors, Inc. (NYSE:NHI) posted its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.29 by $0.36, MarketWatch Earnings reports. The business had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period last year, the firm earned $1.22 earnings per share. National Health Investors updated its FY17 guidance to $5.22-5.26 EPS.
Shares of National Health Investors (NYSE NHI) traded down 0.62% on Friday, reaching $78.63. 180,659 shares of the company were exchanged. The company’s 50-day moving average price is $77.28 and its 200 day moving average price is $75.17. National Health Investors has a 12 month low of $66.31 and a 12 month high of $82.53. The company has a market cap of $3.22 billion, a price-to-earnings ratio of 20.19 and a beta of 0.56.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 4.83%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s dividend payout ratio is currently 97.69%.
A number of research firms recently weighed in on NHI. BidaskClub downgraded shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Bank of America Corporation downgraded shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target for the company. in a research note on Monday, May 22nd. ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a report on Wednesday, May 10th. Finally, Stifel Nicolaus boosted their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $79.60.
ILLEGAL ACTIVITY WARNING: “National Health Investors, Inc. (NYSE:NHI) Releases Quarterly Earnings Results, Misses Expectations By $0.36 EPS” was posted by BNB Daily and is the property of of BNB Daily. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.baseball-news-blog.com/2017/08/19/national-health-investors-inc-nysenhi-announces-earnings-results-beats-estimates-by-0-03-eps-updated.html.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.